Shi K - Search Results

1

Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway.

Xiang Y, Ye W, Huang C, Yu D, Chen H, Deng T, Zhang F, Lou B, Zhang J, Shi K, Chen B, Zhou M. Xiang Y, et al. Among authors: shi k. Oxid Med Cell Longev. 2018 Apr 18;2018:2360427. doi: 10.1155/2018/2360427. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29849873 Free PMC article.

2

Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection.

Huang S, Huang GQ, Zhu GQ, Liu WY, You J, Shi KQ, Wang XB, Che HY, Chen GL, Fang JF, Zhou Y, Zhou MT, Chen YP, Braddock M, Zheng MH. Huang S, et al. PLoS One. 2015 Jun 9;10(6):e0129000. doi: 10.1371/journal.pone.0129000. eCollection 2015. PLoS One. 2015. PMID: 26057656 Free PMC article.

3

Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.

Zhu GQ, Shi KQ, Yu HJ, He SY, Braddock M, Zhou MT, Chen YP, Zheng MH. Zhu GQ, et al. Oncotarget. 2015 Jul 20;6(20):18151-61. doi: 10.18632/oncotarget.4098. Oncotarget. 2015. PMID: 26061709 Free PMC article. Review.

4

Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis.

Zhu GQ, Huang S, Huang GQ, Wang LR, Lin YQ, Wu YM, Shi KQ, Wang JT, Zhou ZR, Braddock M, Chen YP, Zhou MT, Zheng MH. Zhu GQ, et al. Oncotarget. 2015 Sep 15;6(27):24533-49. doi: 10.18632/oncotarget.4528. Oncotarget. 2015. PMID: 26109432 Free PMC article. Review.

5

Combined AFP-CRUT with microvascular invasion accurately predicts mortality risk in patients with hepatocellular carcinoma following curative liver resection.

Huang GQ, Zhu GQ, Huang S, You J, Shi KQ, Hu B, Ruan LY, Zhou MT, Braddock M, Zheng MH. Huang GQ, et al. Expert Rev Gastroenterol Hepatol. 2015;9(8):1127-38. doi: 10.1586/17474124.2015.1057503. Expert Rev Gastroenterol Hepatol. 2015. PMID: 26186642

6

A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.

Zhu GQ, Shi KQ, Huang GQ, Wang LR, Lin YQ, Braddock M, Chen YP, Zhou MT, Zheng MH. Zhu GQ, et al. Oncotarget. 2015 Sep 29;6(29):26757-69. doi: 10.18632/oncotarget.5610. Oncotarget. 2015. PMID: 26378046 Free PMC article.

7

Prognostic value of DNA repair based stratification of hepatocellular carcinoma.

Lin Z, Xu SH, Wang HQ, Cai YJ, Ying L, Song M, Wang YQ, Du SJ, Shi KQ, Zhou MT. Lin Z, et al. Sci Rep. 2016 May 13;6:25999. doi: 10.1038/srep25999. Sci Rep. 2016. PMID: 27174663 Free PMC article.

8

A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.

Xu J, Shi KQ, Chen BC, Huang ZP, Lu FY, Zhou MT. Xu J, et al. J Gastroenterol Hepatol. 2017 Jul;32(7):1394-1402. doi: 10.1111/jgh.13676. J Gastroenterol Hepatol. 2017. PMID: 27973703

9

A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.

Lin Z, Cai YJ, Chen RC, Chen BC, Zhao L, Xu SH, Wang XD, Song M, Wu JM, Wang YQ, Zhou MT, Shi KQ. Lin Z, et al. Clin Chim Acta. 2017 Jun;469:171-179. doi: 10.1016/j.cca.2017.03.026. Epub 2017 Mar 30. Clin Chim Acta. 2017. PMID: 28365450

10

TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling.

Zhu Y, Zhao L, Shi K, Huang Z, Chen B. Zhu Y, et al. Among authors: shi k. Exp Cell Res. 2018 Jun 15;367(2):274-281. doi: 10.1016/j.yexcr.2018.04.006. Epub 2018 Apr 6. Exp Cell Res. 2018. PMID: 29627320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,689 results

Search Page

Filters